0000000001078980
AUTHOR
Chien-lung Huang
showing 2 related works from this author
Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry
2021
OBJECTIVE: The soluble guanylate cyclase stimulator riociguat is approved for the treatment of adult patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension following Phase 3 randomized trials. The EXPosurE Registry RiociguaT in patients with pulmonary hypertension (EXPERT) study was designed to monitor the long-term safety of riociguat in clinical practice. METHODS: EXPERT was an international, multicenter, prospective, uncontrolled, non-interventional cohort study of patients treated with riociguat. Patients were followed for at least 1 year and up to 4 years from enrollment or until 30 days after stopping ri…
Quantum critical point in the itinerant ferromagnet Ni$_{1-x}$Rh$_x$
2020
We report a chemical substitution-induced ferromagnetic quantum critical point in polycrystalline Ni$_{1-x}$Rh$_x$ alloys. Through magnetization and muon spin relaxation measurements, we show that the ferromagnetic ordering temperature is suppressed continuously to zero at $x_{crit} = 0.375$ while the magnetic volume fraction remains 100% up to $x_{crit}$, pointing to a second order transition. Non-Fermi liquid behavior is observed close to $x_{crit}$, where the electronic specific heat $C_{el}/T$ diverges logarithmically, while immediately above $x_{crit}$ the volume thermal expansion coefficient $\alpha_{V}/T$ and the Gr\"uneisen ratio $\Gamma = \alpha_{V}/C_{el}$ both diverge logarithmic…